Celltrion Pharm Balance Sheet Health
Financial Health criteria checks 0/6
Insufficient data to determine the health of Celltrion Pharm
Key information
n/a
Debt to equity ratio
n/a
Debt
Interest coverage ratio | n/a |
Cash | n/a |
Equity | n/a |
Total liabilities | n/a |
Total assets | n/a |
Recent financial health updates
Recent updates
Does Celltrion Pharm (KOSDAQ:068760) Deserve A Spot On Your Watchlist?
May 05Do Institutions Own Celltrion Pharm, Inc. (KOSDAQ:068760) Shares?
Mar 03These 4 Measures Indicate That Celltrion Pharm (KOSDAQ:068760) Is Using Debt Reasonably Well
Feb 02Do Celltrion Pharm's (KOSDAQ:068760) Earnings Warrant Your Attention?
Dec 29Celltrion Pharm, Inc.'s (KOSDAQ:068760) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Nov 24Financial Position Analysis
Short Term Liabilities: Insufficient data to determine if A068760's short term assets cover its short term liabilities.
Long Term Liabilities: Insufficient data to determine if A068760's short term assets cover its long term liabilities.
Debt to Equity History and Analysis
Debt Level: Insufficient data to calculate A068760's net debt to equity ratio to determine if it is satisfactory.
Reducing Debt: Insufficient data to determine if A068760's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: Insufficient data to determine if A068760's debt is well covered by operating cash flow.
Interest Coverage: Insufficient data to determine if A068760's interest payments on its debt are well covered by EBIT.